INTRODUCTION
Peroxisomes perform a range of different metabolic functions, including β-oxidation of fatty acids (FAs) and synthesis and degradation of bioactive, lipid-derived molecules (1) . Substrates for peroxisomal catabolism, e.g. free fatty acids (FFA), can enter the organelles through passive diffusion (2) or by means of ATP binding cassette (ABC) transporters, belonging to subclass D (3, 4) ; see also Fig. 1 ) or via the recently identified porin Pxmp2 (5) . Functional ABC transporters are composed of a minimum of four functional domains: two transmembrane domains, involved in substrate binding and translocation, and two nucleotide binding domains (NBDs) that bind and hydrolyze ATP, thus providing energy for the transport step (6, 7) . These domains may be present in a single polypeptide, i.e. a full-size transporter or as two polypeptides each composed of a transmembrane domain fused to an NBD, i.e. half-size transporters, which hetero-or homodimerize to form a functional transporter.
The yeast Saccharomyces cerevisiae contains two genes that encode peroxisomal half-size ABC proteins: Pxa1p (peroxisomal ABCtransporter 1), and Pxa2p (8) (9) (10) . The single pxa1Δ or pxa2Δ deletion mutants are unable to grow on oleate (C18:1) as the sole carbon source and exhibit reduced β-oxidation of this long chain FA. It has been proposed that Pxa1p and Pxa2p operate as a heterodimer to form a functional transporter for long-chain CoA esters (e.g. C18:1) (8, 9, 11, 12) . Short-chain FAs, as well as medium-chain FAs (e.g. C12:0), presumably enter yeast peroxisomes by passive diffusion as free acids, independently of Pxa1/Pxa2p, and are subsequently activated by the peroxisomal acyl-CoA synthetase Faa2p, which is localized on the peroxisomal periphery, prior to β-oxidation (8) . In addition, there is a second acyl-CoA synthetase Fat1p, which is not only present on the peroxisomal membrane, but also on the plasma membrane, ER and lipid bodies.
In a previous report (13) we have shown that the phenotype of the pxa1/pxa2 yeast mutant, i.e. impaired growth on oleate-containing medium and deficient in oxidation of oleic acid, can be partially rescued by human ABCD1 (HsABCD1) and human ABCD2 (HsABCD2). Full rescue of -oxidation activity in cells expressing human ABCD2 was observed with C22:0 and various unsaturated very long chain fatty acids. In contrast, full rescue was observed for C24:0 and C26:0 -oxidation in cells expressing HsABCD1, the protein involved in X-ALD, which indicates that both proteins are functional homologues of Pxa1/Pxa2p and can both function as homodimers. Two different models for peroxisomal fatty acid transport are described in literature (see Fig. 1 and (14,15)) for yeast and plant cells, respectively. In model A, the ABC transporters deliver esterified fatty acids directly to the peroxisomal matrix, while in parallel free fatty acids (FFA) may enter the peroxisomal matrix via passive diffusion, after which they are subjected to esterification. According to model B the ABC transporters hydrolyse the CoA esters prior to their entry into the peroxisomes, after which the latter are re-esterified by a peroxisomal synthethase (Model B) (16) (17) (18) (19) (20) . In Trypanosoma brucei the glyoxysomal ABC transporter GAT1 serves to transport oleoyl-CoA and presumably other long chain acyl-CoAs from the cytosol to the glyoxysomal lumen (21) , which is in line with the findings described above for yeast. Also in the plant Arabidopsis thaliana a functional equivalent to Pxa1/Pxa2p has been detected, named Comatose (CTS; AtABCD1; AtPXA1) (16) (17) (18) (19) (20) . Unlike the yeast-and the mammalian peroxisomal ABC proteins, CTS is a full-size ABC transporter with dissimilar amino-and carboxy-terminal halves. CTS was able to rescue the oleategrowth phenotype of the pxa1/pxa2 mutant, and restored β-oxidation of fatty acids, which shows that this transport system is a functional homologue of Pxa1/Pxa2p too. Interestingly, when expressed in yeast peroxisomal membranes, the basal ATPase activity of CTS could be stimulated by fatty acylCoAs but not by fatty acids (22) . However, genetic evidence with mutants in which peroxisomal acyl-CoA synthetases were deleted (14, 15, 23) , suggested that CTS delivers fatty acid moieties to the peroxisomal lumen (Fig. 1B) .
The above results prompted us to investigate the molecular mechanism of transport as facilitated by Pxa1/Pxa2p and its orthologues from higher eukaryotes. The conclusion from our experiments is that the ABC transporters accept acyl-CoA esters as their transport substrate, but that only the fatty acid moiety is actually transported, after a hydrolysis step. Upon entry into the peroxisomes the translocated fatty acids are re-esterified with CoA by the CoA-ester synthetase(s) Faa2p and/or Fat1p.
EXPERIMENTAL PROCEDURES
Yeast strains and culture conditions S. cerevisiae BJ1991 (Mat-alpha, leu2, trp1, ura3-251, prb1-1122, pep4-3, gal2) was used as the wild type strain (WT). The following derivatives of this strain, all impaired in ß-oxidation, were used: fox2Δ and fox3Δ (carrying a deletion of the peroxisomal bifunctional protein or 3-keto acyl-CoA thiolase, respectively), pxa1Δ and pxa2Δ (deletion mutants of the peroxisomal ABC transporters 1 and 2 respectively) and faa2Δ (carrying a deletion of the peroxisomal acyl-CoA synthetase). These mutants were constructed from BJ1991 as described previously (8, 11) . The double mutant pxa1/pxa2Δ and ABCD1 or ABCD2 plasmids used in this study were as described before (13 
CPT2 expression plasmids
The ORF encoding mature Carnitine Palmitoyl Transferase 2 (CPT2) (i.e. with its mitochondrial targeting sequence deleted) was amplified using forward primer TATAGGATCC ATG AGC GCC GGC TCC GGG CCC GGC CAG TAC CTG CAG and reverse primer TATAGCATGC TTA AAG CTT ACT TTT GAT GGA TTT GCC TTC containing a KL* extension (restriction sites are underlined). An additional HindIII site was included in the reverse primer, which facilitates 3'-modifications. As template for the PCR we used the pYES2-CPT2 plasmid, containing the ORF of HsCPT2 (generous gift from Dr. F. Taroni, Milano, Italy). The resulting PCR product was cloned in pGEM-T to generate pGEM-T-CPT2-SKL. The plasmid pCPT2per1 was made by subcloning the BamHI SphI fragment of pGEM-T-CPT2-SKL into the yeast expression vector Pca31, which contains the oleateinducible catalase promoter (24) plus an oligonucleotide adaptor encoding the Nterminus of the mature haemagglutinin protein, as described in detail in Elgersma et al. (25, 25) . For expression of CPT2 in the cytosol (pCPTcyt) the peroxisomal targeting signal (SKL) was replaced by the C-terminal end of the native CPT2. To this end, the NcoI-SphI fragment from pYES2-CPT2 was cloned into pCPT2per1, which was digested by NcoI and SphI. The HindIII site (upstream of the stop codon) in pCPT2per1 was used to enhance the effectiveness of the peroxisomal targeting signal (SKL) by insertion of the following linker: AG CTT GGT TCC GGA GGT GAA GCT GCA GTT AAG CTT TCT CAA GCT AAA TCT AAA CTT TAATCTAGAT, antisense AGCTATCTAGA TTA AAG TTT AGA TTT AGC TTG AGA AAG CTT AAC TGC AGC TTC ACC TCC GGA ACC A, which encodes the 12 C-terminal amino acids of FOX2 (peroxisomal targeting signal 1) preceded by a flexible loop, and resulting in pCPT2per2. In pCPT2per3 the flexible loop was replaced by an α-helical linker (26) to modify the accessibility of the PTS1 signal. To this end, pCPT2per2 was cleaved by HindIII and the following linker was inserted: sense AG CTA GCA GCT AAA GAA GCC GCA GCT AAA GAA GCC GCA GCT AAA GAA GCC GCA GCT AAA GAA GCT GCA GTT A, antisense AG CTT AAC TGC AGC TTC TTT AGC TGC GGC TTC TTT AGC TGC GGC TTC TTT AGC TGC GGC TTC TTT AGC TGC T. All inserts were verified by DNA sequencing. In summary, the C-terminus of these four CPT2 derivatives is as follows (extensions in bold face): pCPT2cytEGKSIKS; pCPT2-per1 EGKSIKSKL; pCPT2-per2 EGKSIKSKLG SGGEAAVKLS QAKSKL; pCPT2-per3 EGKSIKSKLA AKEAAAKEAA AKEAAAKEAA VKLSQAKSKL.
Mass spectrometric metabolite analyses
To compare the acyl-CoA levels in different cellular compartment we first transformed the yeast cells with human carnitinepalmitoyltransferase 2 (HsCPT2) with or without a peroxisomal targeting signal. After growing for at least 24 hr on 0.3g/L glucose plus amino acids (20mg/L), yeast cells were grown overnight on YPO+ medium. Isolated yeast cells were washed and incubated (OD = 2.5) for 60 or 180 min with 400 μM caprylic (C8:0) acid and 0.33 g/LTween-80 or 2.4 mM oleic acid (C18:1) and 2 g/LTween-80, respectively in 3 g/L yeast extract, 5 g/L bactopepton, 25 mM potassium phosphate (pH = 6.0) and 2 mM carnitine. Of this mixture, 2 ml were spun down and cell pellets were stored at -80C. For measurements of O 18 incorporation into 3-OH acyl-carnitine intermediates, cells were incubated as described above with 50%
as the only adjustment. For acyl-carnitine measurements pellets were taken up in 500 μL 70% (v/v) acetonitrile. Acyl-carnitine levels were determined by liquid chromatography-tandem mass spectrometry as described previously (27, 28) , using [ 2 H 3 ]-palmitoyl-carnitine as internal standard.
Subcellular fractionation and Nycodenz gradient centrifugation. In order to prepare a peroxisome-enriched fraction, subcellular fractionation by differential centrifugation of S. cerevisiae homogenates was performed as described before (10) . Organellar pellets were layered on top of a 150 to 350g/L Nycodenz gradient (12 mL), with a cushion of 1.0 mL of 500g/L Nycodenz solution. All Nycodenz solutions contained 5 mM MES (morpholinoethanesulfonic acid, pH 6.0), 1 mM EDTA, 1 mM KCl, and 85g/L sucrose. The sealed tubes were centrifuged for 2.5 h in a vertical rotor (MSE 8x35) at 19,000 rpm and 4°C. After centrifugation, gradients were aliquotted into different fractions, which were assayed for activity of various marker enzymes as described below.
Enzyme assays Beta-oxidation assays in intact cells were performed as described previously by van Roermund et al. (29) with slight modifications. Cells were grown overnight in media containing oleate to induce -oxidation. The -oxidation capacity was measured in 50mM MES (pH=6.0), supplemented with 10 μM [1-14 C]-fatty acids. Subsequently, [ 14 C]-CO 2 was trapped with 2 M NaOH and used to quantify the rate of fatty acid oxidation. Results are presented in %, relative to the rate of oxidation of wild type cells. In WT cells the rates of lauric acid (C12:0, 1hr incubation) and behenic acid (C22:0, 2hr incubation) oxidation were 7.24 ± 0.80 and 0.62 ± 0.08 nmol/min.10 7 cells, respectively, whereas lignoceric acid (C24:0, 2.5 hr incubation) was oxidized with a rate of 4.46 ± 0.15 pmol/hr.10 7 cells. Acyl-CoA synthetase activity was measured as described by Knoll et al. (30) , with the following modifications. The reaction was started by adding cell extract to a mixture of 10μM [1- 14 C]-C22:0, 150mM Tris (pH=8.5), 10mM ATP, 10mM MgCl 2 , 200μM CoA and 1g/L Triton X-100, and incubated for 10 min at 28°C. The activity of the peroxisomal marker 3-hydroxyacyl-CoA dehydrogenase (3HAD) was measured on a Cobas-Fara centrifugal analyzer by monitoring the acetoacetyl-CoA dependent rate of NADH consumption at 340 nm (31) . Fumarase activity was measured on a CobasFara centrifugal analyzer by monitoring the increase in absorbance at 365 nm for 5 min at 37°C. In the fumarase assay, 3-acetylpyridine adenine dinucleotide (APAD) rather than NAD was used as the cofactor. Its reduced form absorbs at 365 nm (29) . The reaction was started by adding 10 mM fumarate into an incubation mixture containing the following components: 100 mM Tris (pH 9.0), 1g/L Triton X-100, 4 U/mL malate dehydrogenase and 1 mM APAD. Alkaline-phosphatase-and esterase activity was measured on a CobasFara centrifugal analyzer according to published procedures (32) . Protein concentrations were determined by the bicinchoninic acid method described by Smith et al. (33) .
RESULTS

Evidence that Faa2p is involved in HsABCDdependent acyl-CoA transport across the peroxisomal membrane
To determine the chemical nature of the product delivered by the HsABCD complex into the peroxisomes, we measured the -oxidation of C22:0 and C24:0, in pxa1/pxa2 cells as well as in pxa1/pxa2/faa2cells, both expressing either the human HsABCD1 or the HsABCD2 (see panels B and A of Fig. 2 ). Full rescue was observed in pxa1/pxa2cells expressing HsABCD1 or HsABCD2 for C24:0 and C22:0 -oxidation activity, respectively, while no rescue was detected in yeast strains in which -in addition to pxa1/pxa2 -also faa2 was deleted. These results imply that the -oxidation activity in pxa1/pxa2 cells that express HsABCD1 or HsABCD2 is dependent on the intra-peroxisomal acyl-CoA synthetase Faa2p. As a control for proper induction of the -oxidation enzymes, we measured the activity of 3-hydroxyacyl-CoA dehydrogenase (Fig.  2C) . The results indicate that HsABCD1p and HsABCD2p do deliver free fatty acids into the peroxisomal matrix, which, after their import into the peroxisomal lumen, need to be activated into CoA-esters to become substrates for -oxidation.
Measurement of the peroxisomal and cytosolic acyl-CoA pool
To gain more insight into the mechanism of acyl-CoA transport across the peroxisomal membrane, it would be important to be able to determine and compare the acyl-CoA levels in different cellular compartments, e.g. in the cytosol and in the peroxisomal matrix. Measuring acyl-CoA levels in isolated peroxisomes versus cytosol, however, will not provide such information, because peroxisomes become leaky -and therefore permeable for acyl-CoA esters -upon isolation from the cells. We therefore developed an assay to determine these levels in vivo. To this end, we used human carnitinepalmitoyltransferase 2 (HsCPT2), which can convert acyl-CoAs into the corresponding acyl-carnitine esters which then can be readily measured by LC-tandem mass spectrometry (34) . Targeting of HsCPT2 to either the cytosol or to the peroxisomes will provide an assay for determining the amount of acyl-CoA formed in either compartment. To develop this experimental system we designed four different CPT2 constructs, all lacking the authentic mitochondrial targeting signal: One construct will target to the cytoplasm (CPT2cyt) and three constructs, each containing a peroxisomal targeting signal 1 in a different context, will be targeted to peroxisomes (CPT2per1-3; for further details see Materials and Methods). To study the subcellular localization of CPT2cyt and CPT2per1-3 in oleate-grown cells, we transformed these CPT2 constructs to our wild type yeast strain. After fractionation of oleategrown cells into its organellar fractions, we found that CPT2cyt was present exclusively in the supernatant, CPT2per1 in the supernatant as well as in the organellar pellet, whereas CPT2per2 and CPT2per3 were mainly present in the organellar pellet. To separate peroxisomes from mitochondria, the organellar pellets were further fractionated by Nycodenzdensity gradient centrifugation. Immunoblot analysis of the gradient fractions, using CPT2-antibodies, revealed that CPT2cyt co-localized with the cytosolic marker phosphoglucose isomerase (PGI), and both CPT2per2 and CPT2per3 with the peroxisomal marker 3-hydroxyacyl-CoA dehydrogenase (3HAD), thus indicating a cytosolic and peroxisomal localization, respectively (data not shown). Localization of CPT2per1 was 50 % peroxisomal and 50 % cytosolic, indicating that a flexible loop (CPT2per2) or a helical linker (CPT2per3), together with a peroxisomal targeting sequence, is necessary for efficient peroxisomal localization. Figure  3A shows that CPT2cyt and CPT2per2 constructs in situ are actively expressed, as deduced from the measured oleoyl-carnitine levels (for further details see Materials and Methods) in wild type cells growing on oleate/glycerol and expressing CPT2cyt and CPT2per2, respectively. This activity is not observed in wild type cells transformed with an empty vector (not shown). To investigate in vivo the acyl-CoA transport across the peroxisomal membrane we measured the peroxisomal -oxidation intermediate 3-OH oleoyl-CoA, by comparing the levels of 3-OH oleoyl-carnitine in oleate/glycerol-grown yeast cells expressing CPT2per2 and CPT2cyt. Expression of CPT2per2 resulted in markedly higher levels of 3-hydroxy-oleoyl-carnitine in oleate/glycerol-grown fox3 cells (carrying a deletion of the peroxisomal 3-keto acyl-CoA thiolase), when compared to wild type cells or fox2 cells (carrying a deletion of the peroxisomal bi-functional protein), which indicates that peroxisomally expressed CPT2 can indeed be used to determine acyl-CoA levels in the peroxisomes (Fig. 3B) .
CoA-ester hydrolysis occurs before fatty acid oxidation The above described approach to assay acylCoA levels provides a tool to elucidate the mechanism of acyl-CoA synthetase-dependent acyl-CoA transport process across the peroxisomal membrane. When acyl-CoA esters are hydrolyzed during or after the uptake process into the peroxisomes, a water molecule is added to the substrate. In the presence of 50% [
18 O]H 2 O, a theoretical ratio of none-, versus single-, versus double- 18 O incorporation into the 3-hydroxy acyl-CoA ester is expected of: 0.75:1.0:0.25 in the fox3 mutant (Fig. 4A) . Figure 4B shows the 3-OH oleoyl-carnitine levels with different degrees of 18 18 O incorporation in wild type cells, suggests that the hydrolysis step (and subsequent esterification) is an obligatory step prior to -oxidation. As a control we incubated WT and fox3 cells, both transformed with CPT2per with octanoic acid (C8:0) (Fig. 4C ) and observed none-and single 18 O incorporation into the -oxidation intermediate 3-hydroxy-octanoyl-carnitine and none double 18 O incorporation, indicating that C8:0 presumably enters yeast peroxisomes by passive diffusion as a free acid, independently of Pxa1/Pxa2p.
Pxa1/Pxa2p heterodimer forms a functional unit with an additional acyl-CoA synthetase
The C24:0 and C22:0 -oxidation activity in faa2 cells is approximately 50% of the activity in the corresponding wild type strain ( Figs. 2A and 2B ), while no activity can be measured in faa2/pxa1/pxa2 cells. However, when the yeast transporters Pxa1p and Pxa2p are replaced by the human orthologues HsABCD1 or HsABCD2 in faa2/pxa1/pxa2 cells, the residual -oxidation activity is still less than 5% ( Figs. 2A and 2B ). This implies that the C24:0 or C22:0 -oxidation flux, redirected by HsABCD1 and HsABCD2 respectively, is strictly dependent on the presence of the peroxisomal Faa2p. This is somewhat surprising, because we expected, based on the homology between yeast and HsABCD transporters, that the essence of the mechanism of acyl-CoA transport across the peroxisomal membrane would be the same, although their chain-length specificity for CoA-esters may differ. One explanation for this is that the deletion of PXA1/PXA2 also affects a peroxisomal acyl-CoA synthetase activity other than Faa2p. Since there are no recognizable sequence features in the ABCD proteins that suggest that these proteins also display acyl-CoA synthetase activity, we hypothesize that this acyl-CoA synthetase forms a functional protein complex with Pxa1/Pxa2p, but can not form such a complex with HsABCD1 or HsABCD2. To determine the existence of an additional peroxisomal acyl-CoA synthetase for very long chain fatty acids we first optimized the C22:0-CoA synthetase assay in isolated peroxisomes from wild type cells (see Materials and Methods) and then measured the subcellular localization of C22:0-CoA synthetase activity in wild type, faa2 pxa1/pxa2and pxa1/pxa2/faa2 cells grown on oleate/glycerol. In all deletion strains we measured C22:0-CoA synthetase activity in the organellar fraction as well as in the supernatant fraction (Fig. 5A) . After separation of peroxisomes from other organelles by equilibrium-density gradient centrifugation we observed that part of the C22:0-CoA synthetase activity of wild type yeast cells cofractionated with the peroxisomal marker 3-hydroxyacyl-CoA dehydrogenase, whereas the remaining activity co-fractionated with the mitochondrial marker fumarase, the ER marker esterase and the plasma membrane marker alkaline phosphatase (Fig. 5B) . Interestingly, no peroxisomal C22:0-CoA synthetase activity was present in pxa1/pxa2/faa2 yeast cells, which is in marked contrast to the presence of this activity in faa2 cells or pxa1/pxa2 cells. This suggests not only that Faa2p contributes to the activation of C22:0 in peroxisomes, but also points to the existence of an additional acyl-CoA synthetase activity associated directly or indirectly with the ABC transporters Pxa1/Pxa2p.
Fat1p is involved in ABC-transporterdependent acyl-CoA transport
One of the candidates for this presumed additional peroxisomal acyl-CoA synthetase is the previously reported fatty acid transporter protein Fat1p. Fat1p contains the peroxisomal targeting signal IKL and is localized not only in peroxisomes, but also in the plasma membrane, in lipid bodies and in the endoplasmatic reticulum (35) (36) (37) (38) . Fat1p functions in vectorial acylation, which couples the uptake of exogenous fatty acids to their activation into the corresponding CoA esters. Furthermore, it carries a very long chain acylCoA synthetase motif, with its active site on the inner face of the plasma membrane (37) . To confirm that Fat1p indeed is also present in the peroxisomal membrane, double mutants were generated in which both FAA2 and FAT1 were deleted and C22:0-CoA synthetase activity was measured in isolated peroxisomes of fat1 and faa2/fat1 cells. Figure 6A shows that the isolated peroxisomal fraction of fat1/faa2 cells is deficient for C22:0-CoA synthetase activity, indicating that Fat1p is responsible for the peroxisomal C22:0-CoA synthetase activity in the wild type and faa2 strain. To study the involvement of Fat1p in acyl-CoA transport across the peroxisomal membrane, fat1, faa2 and faa2/fat1 cells were subsequently analyzed for C22:0 -oxidation activity. Importantly, fat1 cells showed normal C22:0 -oxidation activity, suggesting that Fat1p is not the rate limiting step of C22:0 -oxidation in wild type yeast (Fig. 6B) . Furthermore, by measuring the C22:0 carnitine levels in fat1 cells expressing CPT2cyt and incubated with C22:0, we could show that the cytosolic concentration of C22:0-CoA was not affected by this deletion (data not shown), indicating that the transport of C22:0 across the plasma membrane in fat1 cells is normal. As a control for constitutive induction of -oxidation enzymes under these conditions we measured the 3-hydroxyacyl-CoA dehydrogenase activity (Fig. 2C) , the third step of the -oxidation pathway. We found that the C22:0 -oxidation was severely affected in faa2/fat1 cells (Fig. 6B) , which indicates that both acyl-CoA synthetases, Faa2p and Fat1p, contribute to the peroxisomal -oxidation of C22:0. Furthermore, whereas C12:0 -oxidation activity is not impaired, consistent with previous observations (7), we observed that C12:0 oxidation is fully dependent on Faa2p (Fig. 6B) .
DISCUSSION
In this study we show that uptake of (very) long chain acyl-CoAs into yeast peroxisomes via the Pxa1/Pxa2p complex is accompanied by hydrolysis of their CoA-ester, followed by re-esterification with co-enzyme A in the peroxisomal lumen. As observations have been made with plant-and mammalian-derived homologues of this system that can be interpreted in a similar way (10, 32) , this mechanism of uptake into the peroxisomes presumably is functional in all eukaryotes. Whereas the plant homologue, Comatose, is a complex, four-domains containing protein, the human homologues are able to function in this uptake process as a homo-dimer. At first sight, such a hydrolysis/reesterification process may seem energetically unfavorable. However, in vitro biochemical studies will be needed to reveal the details of the free energy requirements of the various steps in this process. CoA is only used catalytically in the -oxidation cycle. Hydrolysis of the acyl-CoA prior to transport prevents accumulation of CoA in the peroxisome and makes export of CoA superfluous. Because of this, functional reconstitution of the Pxa1/Pxa2p complex, with and without a coupled acyl-CoA syntethase, in a liposomal system is required to resolve this issue. The observed biochemical mechanism of the uptake process differs significantly from most transport processes, which are mostly energized by either a chemiosmotic mechanism (symport, antiport, etc.), or ATP hydrolysis (see e.g. (39)). The current process shows some similarities with Grouptranslocation mechanisms, be it that it is almost the inverse of the best known example from this class, the phospho-enol pyruvate phospho-transferase system from enterobacteria (40) . However, rather than receiving an additional moiety, here the substrate is reduced in size during the transport step. A key consequence of the mechanism of uptake of very long chain fatty acids into peroxisomes that we report here is that the availability of coenzyme A in the peroxisomal lumen has to be regulated separately by the eukaryotic cell. While this paper was under review Agrimi et al, 2012 (42) provided evidence in favour of a peroxisomal CoA transporter, which could be involved in this regulation.
We also showed (see Fig. 6 and 7 ) that Fat1p has a role in the ABC-transporter-dependent C22:0 fatty acid uptake into peroxisomes. Detection of functional activity of this protein is dependent on the presence of Pxa1/Pxa2p. This may be because the Fat1 protein is associated with the ABC transporters Pxa1/Pxa2p, or because only with these two transporters there is an optimal chain length match. The model proposed in Fig. 7 shows fatty acid interaction with proteins at the peroxisomal membrane either as FFA or as acyl-CoA ester. We do not have solid evidence for free fatty acid transport across the peroxisomal membrane via Fat1p (peroxisomal), but there is evidence that Fat1p is functional as a bi-functional protein, and plays a central role in fatty acid trafficking at the level of long-chain fatty acid transport and very long-chain fatty acid activation (34) (35) (36) (37) . This Fat1p mediated transport is much more energetically favorable than the ABC transporter mediated pathway.
The biochemical hallmark of patients suffering from X-linked adrenoleukodystrophy (X-ALD) is the significant accumulation of saturated, straight chain very long chain fatty acids (VLCFA; C24:0 and C26:0) and mono unsaturated VLCFA (C26:1) in plasma and various tissues. Initially, the elevated VLCFA levels occurring in X-ALD were predicted to be caused by a reduced activity of VLCFA acyl-CoA synthetase (VLACS) and thus it was thought that VLACS was the candidate gene to be defective in X-ALD. However, positional cloning identified the HsABCD1 gene as defective in X-ALD. Although the involvement of VLACS has been disputed (41), our current findings explain why coexpression of ALDP and VLACS has a synergistic effect on -oxidation and VLACS activity, and leads to a functional, rather than a physical interaction of VLACS and ABC transporters. Confusingly, there is no clear cut correlation between genotype and phenotype in X-ALD patients. For example no correlations could be identified between the nature of the ABCD1 mutations, level of VLCFA accumulation, and severity of the pathology of X-ALD. In our transport model (Fig. 7) we can divide the process of acyl-CoA transport across the peroxisomal membrane into three steps: 1. hydrolysis of the acyl-CoA ester, 2. transport of the fatty acid across the peroxisomal membrane, and 3. re-esterification of the fatty acid to an acyl-CoA ester. Not only could a defect of one of these three steps lead to an accumulation of VLCFAs and/or VLCFA-CoA esters, but also the level of the peroxisomal acyl-CoA synthetase activity or the cytosolic CoA concentration could influence the accumulation of VLCFAs and /or VLCFACoA esters. Each of these could have a different influence on the pathology of individual ALD patients, thereby giving rise to multiple phenotypes. The mechanism of hydrolysis of VLCFA-CoA esters, and the transport and re-esterification of the VLCFAs will be investigated in future studies by using humanized yeast as an in vivo model system or in vitro by functional reconstitution of the Pxa1/Pxa2p complex in a liposomal system. In summary: We provide evidence that in S. cerevisiae acyl-CoA esters are hydrolysed prior to the actual transport into the peroxisomes by the Pxa1/Pxa2 complex, with the CoA presumably being released into the cytoplasm.
The Pxa1/Pxa2 complex functionally interacts on the inner surface of the peroxisomal membrane with the acyl-CoA synthetases Faa2p and/or Fat1p for subsequent re-esterification of the VLCFAs. Figure 5B cytosoll
